Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nano-X Imaging (NNOX) EBITDA (2020 - 2025)

Historic EBITDA for Nano-X Imaging (NNOX) over the last 6 years, with Q3 2025 value amounting to -$13.7 million.

  • Nano-X Imaging's EBITDA fell 81.03% to -$13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.7 million, marking a year-over-year decrease of 1360.59%. This contributed to the annual value of -$53.2 million for FY2024, which is 997.34% up from last year.
  • Nano-X Imaging's EBITDA amounted to -$13.7 million in Q3 2025, which was down 81.03% from -$14.7 million recorded in Q2 2025.
  • Nano-X Imaging's EBITDA's 5-year high stood at -$9.9 million during Q4 2023, with a 5-year trough of -$52.4 million in Q4 2022.
  • Its 5-year average for EBITDA is -$17.4 million, with a median of -$13.7 million in 2021.
  • In the last 5 years, Nano-X Imaging's EBITDA plummeted by 13317.3% in 2022 and then soared by 8107.62% in 2023.
  • Nano-X Imaging's EBITDA (Quarter) stood at -$22.5 million in 2021, then crashed by 133.17% to -$52.4 million in 2022, then soared by 81.08% to -$9.9 million in 2023, then crashed by 42.06% to -$14.1 million in 2024, then grew by 2.76% to -$13.7 million in 2025.
  • Its EBITDA stands at -$13.7 million for Q3 2025, versus -$14.7 million for Q2 2025 and -$13.2 million for Q1 2025.